Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

< Under the microscope: In the brain section of an MS patient, the neurons are shown in green and the ... University Hospital Bonn (UKB) / Research group Prof. Stefanie Kürten ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

Multiple Sclerosis Association of America is proud to support Multiple Sclerosis Awareness Month during the month of March ...

This segment is sponsored by Genetech.March is Multiple Sclerosis Awareness Month, but how much do you really know about this chronic disease?Today on Living O ...

As a growing body of research points to the potential for cannabis as a catalyst for climax, WH asks if this is the year that ...

Silo Pharma (NASDAQ: SILO) , a developmental-stage biopharmaceutical company, has filed a provisional patent application with the U.S. Patent and Tra ...

Esoteric Testing Market Research Report In 2022, the global esoteric testing market was valued at $24.2 billion and projected reach $68.5 b ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) shared new and updated results from its RESET clinical development ...

A sponge-like implant in mice has helped guide a treatment that slowed or stopped a degenerative condition similar to ...

The world is full of nasty and deadly diseases, but some of the worst are the ones that turn your own body against you.